Sponsor or institution
Clinical trials and research at The First Hospital of Jilin University
As of November 12, 2026, Find a Trial lists 53 clinical trials run by The First Hospital of Jilin University that are recruiting, in China. 3 were first registered in the last 30 days. By phase: Phase 2 (10), Phase 3 (4), Phase 4 (3), Phase 1/2 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 53Clinical trials
- 3New in 30 days
- 1Country
Newest trials
All recruiting trials (53)
-
Retroperitoneal Tumor Registry
This observational registry collects real-world data from people with retroperitoneal tumors to help understand features, treatments, and long-term outcomes.
-
Polatuzumab Vedotin plus Rituximab with Reduced-dose chemo for frail seniors with DLBCL
This trial tests whether a gentler, first-line treatment (Polatuzumab Vedotin with Rituximab and reduced-dose chemo) helps older, frail patients with DLBCL stay disease-free longer.
-
Vision-language AI helps emergency CT readers spot thoraco-abdominal problems
This trial tests whether a self-developed AI model can help radiologists find acute thoraco-abdominal emergencies on CT scans more accurately than standard reading in adult emergency patients.
-
Tegileridine for pain after bariatric surgery
This phase 3 trial tests tegileridine vs standard opioid medicine to see if it provides good pain relief after bariatric surgery while considering sleep apnea status.
-
Modular robotic surgery to remove GEJ cancers at Siewert II/III
This trial tests a modular robotic system to perform minimally invasive removal of Siewert type II/III gastroesophageal junction cancers in adults.
-
Removing enlarged cardiophrenic lymph nodes during surgery for advanced ovarian cancer
This will try removing enlarged cardiophrenic lymph nodes during surgery in women with advanced ovarian, fallopian tube, or primary peritoneal cancer to see if it delays cancer coming back and is safe.
-
Second-line combination treatment for MSS metastatic colorectal cancer
This trial will try folinic acid plus continuous 5-FU with liposomal irinotecan, sometimes combined with cetuximab or bevacizumab, as a second-line option for adults with MSS metastatic colorectal cancer who progressed on or cannot tolerate oxaliplatin-based therapy.
-
Pressurized intraperitoneal aerosol chemotherapy (PIPAC) versus standard neoadjuvant chemotherapy for advanced high-grade serous ovarian cancer
This trial will test whether giving chemotherapy as a pressurized abdominal aerosol (PIPAC) before surgery helps women with advanced high-grade serous ovarian cancer get a stronger tumor response than standard pre-surgery chemotherapy.
-
IL-15–armored CAR-T for relapsed or refractory multiple myeloma and plasma cell leukemia
This trial will test IL-15–armored CAR-T cell therapy to see if it helps adults with relapsed or refractory multiple myeloma or plasma cell leukemia, including those with persistent or returning MRD.
-
Short-course radiotherapy then CapeOX and toripalimab, with or without surufatinib, before surgery for high-risk mid-to-low rectal cancer
This trial tests whether adding surufatinib to short-course radiotherapy followed by CapeOX chemotherapy plus toripalimab before surgery improves tumor response in adults with high-risk mid-to-low rectal cancer.
-
Daphnetin plus TC chemotherapy and targeted maintenance after surgery for stage III–IV epithelial ovarian cancer
This trial tests whether adding daphnetin capsules to standard paclitaxel‑carboplatin chemotherapy and then combining daphnetin with targeted maintenance can help people with stage III–IV epithelial ovarian cancer who had R0 or R1 surgery.
-
CapsuleX combined with cisplatin for platinum-resistant recurrent ovarian cancer
This study will try adding CapsuleX to cisplatin to see if it helps people with platinum-resistant recurrent ovarian cancer have better tumor responses.
-
Paiteling® antibacterial liquid for persistent cervical high‑risk HPV infection
This trial will test whether Paiteling® antibacterial liquid applied to the cervix can clear persistent high‑risk HPV infection in women aged 25–65.
-
Chidamide with reduced-dose R-mini CHOP followed by chidamide plus CD20 antibody maintenance for elderly MYC/BCL2 double-expressor DLBCL
This trial tests whether adding chidamide to reduced-dose R-mini CHOP, followed by chidamide plus a CD20 antibody, helps people aged 70 and older with newly diagnosed MYC/BCL2 double-expressor DLBCL live longer without disease progression.
-
Chidamide as maintenance for HBV-positive diffuse large B‑cell lymphoma after R‑CHOP
This trial tests whether taking chidamide as maintenance helps adults with HBV-positive diffuse large B‑cell lymphoma who achieved a complete response after R‑CHOP.
-
Predicting blood clots after lung cancer surgery
This project will try to use clinical, surgical, and lab data to predict which adults having lung cancer surgery may develop blood clots after the operation.
-
Comparing protein patterns in extracellular vesicles from different blood vessels in people with ruptured or unruptured brain aneurysms
This project tries to see if protein differences in extracellular vesicles taken from different blood vessels can help diagnose or predict outcomes for people with ruptured or unruptured brain aneurysms undergoing neurointerventional procedures.
-
Sintilimab plus chemotherapy after surgery for mucosal melanoma
This test will see if adding the immunotherapy drug sintilimab to standard chemotherapy after surgery helps people with PD-L1–positive mucosal melanoma stay cancer-free longer.
-
Turnbull-Cutait versus low anterior resection to avoid a permanent stoma in low rectal cancer
This study will try whether Turnbull-Cutait delayed coloanal anastomosis or low anterior resection with a protective stoma better keeps adults with low rectal cancer stoma-free over three years.
-
Intelligent app-based diagnosis and treatment program for insomnia
This trial will try an intelligent, app-delivered cognitive behavioral therapy program to help adults with insomnia sleep better and reduce treatment costs.
-
Tamsulosin and Early Catheter Removal After Rectal Cancer Surgery
This trial tests whether removing a urinary catheter at 24 hours, 48 hours, or early removal with tamsulosin helps people after mid-low rectal cancer surgery see fewer catheter-related problems.
-
Transcranial current stimulation to help insomnia
This trial tests whether mild electrical stimulation of the scalp can help adults with psychophysiological insomnia sleep better and normalize brain activity.
-
Biomarkers and Gastric Motility Index to Predict Feeding Intolerance in Critically Ill Adults
This observational study tests whether certain biomarkers and gastric motility measurements can predict feeding intolerance in critically ill adults who cannot eat by mouth but may start tube feeding within 48 hours in the ICU.
-
PRE-VAIL: reducing enteral feeding before prone positioning for severe ARDS
This trial tests whether temporarily reducing tube feeding before turning adults with moderate-to-severe ARDS onto their stomachs lowers stomach pressure and feeding problems.
-
Using subharmonic imaging with liver stiffness and platelet count to find high-risk esophageal and gastric varices in people with cirrhosis
This tests whether combining subharmonic-assisted pressure estimation, a liver stiffness measurement, and platelet count can identify adults with liver cirrhosis who have high-risk esophageal or gastric varices.
-
Goal-oriented albumin infusion to reduce complications after gastric cancer surgery
This test tries to see if giving albumin when blood levels drop below 25 g/L instead of 30 g/L after gastric cancer surgery reduces serious postoperative complications in adults.
-
Timing of supplemental parenteral nutrition in critically ill adults
This trial will test whether starting supplemental parenteral (intravenous) nutrition on day 4 versus day 8 after ICU admission reduces 28-day death in critically ill adults who cannot meet calorie needs with enteral feeding.
-
Venetoclax plus azacitidine as a bridge to stem-cell transplant for higher-risk MDS-IB2
This will test whether 1–2 cycles of venetoclax with azacitidine can lower bone marrow blasts and help adults with higher‑risk MDS‑IB2 reach allogeneic stem-cell transplantation.
-
Nefecon (budesonide) plus ambrisentan for IgA nephropathy with proteinuria
This test will see if combining Nefecon (a gut‑targeted budesonide) with ambrisentan can reduce urine protein and slow kidney decline in adults with IgA nephropathy who have at least 0.5 g of protein in a 24‑hour urine collection.
-
Optimizing AML treatment using early peripheral blood minimal residual disease
This trial tests whether adding venetoclax based on early peripheral blood minimal residual disease can help adults with newly diagnosed AML who have a suboptimal early response to chemotherapy.
-
Medium-dose cytarabine plus venetoclax for consolidation in older adults with intermediate- or high-risk AML
This study will try giving medium-dose cytarabine together with venetoclax as consolidation therapy to people aged 60–75 with intermediate- or high-risk AML who are in remission after induction.
-
Using AI to improve diagnosis of colorectal lesions during endoscopy
This study is testing if using real-time artificial intelligence during colonoscopies can help doctors better identify colorectal lesions and reduce unnecessary surgeries.
-
Comparing AI-assisted endocytoscopy for colorectal lesions
This study is testing if using artificial intelligence during colon exams can help doctors better identify different types of colorectal lesions to improve patient care.
-
Evaluating a new treatment for advanced colorectal cancer
This study is testing a new combination treatment for advanced colorectal cancer to see if it can help patients who haven't had success with other therapies.
-
AI-guided app to help manage type 2 diabetes
This project will try an AI-guided app that uses glucose and activity data to give adults with type 2 diabetes personalized medication, diet, and exercise suggestions to help lower blood sugar.
-
New treatment approach for primary central nervous system lymphoma
This study is testing a new combination of treatments for people with newly diagnosed primary central nervous system lymphoma to see if it can help them respond better and stay healthy longer.
-
Using iTBS to treat acute ischemic stroke after thrombectomy
This study is testing if a new brain stimulation treatment can help adults recover better after having a stroke and getting a blood clot removed.
-
Evaluating how different surgical methods affect quality of life after stomach surgery
This study is testing how different types of stomach surgery affect the quality of life for people recovering from early-stage gastric cancer.
-
Observing MRD's role in local treatment for oligometastatic breast cancer
This study is trying to see if measuring minimal residual disease (MRD) can help doctors figure out which patients with oligometastatic breast cancer will do better after local treatment.
-
Robotic surgery for advanced gastric cancer
This study is testing if robotic surgery can safely help people with advanced stomach cancer by reducing blood loss and hospital stays compared to traditional methods.
-
Combining Ivonescimab with Chemotherapy for Mesothelioma Treatment
This study is testing if adding a new drug called ivonescimab to chemotherapy can help people with pleural mesothelioma who haven't had success with other treatments.
-
Modified feeding regimen for critically ill adults guided by a feeding-intolerance prediction model
This trial tests whether using a prediction model to guide enteral feeding schedules helps critically ill adult ICU patients tolerate and receive nutrition better.
-
Using AI to improve the diagnosis of small colorectal polyps
This study is testing whether using AI during colonoscopy can help doctors find small colorectal polyps more accurately, which could reduce unnecessary procedures for patients.
-
Hypofractionated radiotherapy for glioblastoma treatment
This study is testing a new way of giving radiation therapy combined with a medication for people with newly diagnosed glioblastoma to see if it helps them live longer.
-
Combination treatment for marginal zone lymphoma patients
This study is testing a new combination of two drugs, Linperlisib and obinutuzumab, to see if they can safely help patients with marginal zone lymphoma as their first treatment.
-
Daratumumab with pomalidomide and dexamethasone for first-relapse multiple myeloma
This will follow people with first-relapse multiple myeloma who receive daratumumab plus pomalidomide and dexamethasone to see if they go longer before the next progression than people on other contemporary regimens.
-
Dynamic frailty-tailored therapy for elderly patients with newly diagnosed multiple myeloma
This study is testing a new treatment plan for older patients with newly diagnosed multiple myeloma to see if adjusting their therapy based on their fitness level helps them tolerate the treatment better and have improved outcomes.
-
Early use of tirofiban after thrombolysis for acute ischemic stroke
This study is testing if giving tirofiban right after a stroke treatment can help patients recover better and stay safe.
-
Balloon angioplasty for minor strokes and TIAs caused by intracranial atherosclerosis
This study is testing if adding balloon angioplasty to standard medical treatment can help people who have had minor strokes or TIAs caused by narrowed brain arteries feel better and have fewer problems.
-
Exploring biomarkers in neurological diseases
This study is trying to find new signs in brain and body samples that could help doctors diagnose and predict the outcomes of neurological diseases better.
-
Treatment for newly diagnosed high tumor burden non-Hodgkin's lymphoma
This study is testing a new treatment combination for people with newly diagnosed high tumor burden non-Hodgkin's lymphoma to see if it helps them feel better and stay safe.
-
Neoadjuvant treatment for advanced acral melanoma
This study is testing a new combination treatment for patients with advanced acral melanoma to see if it helps shrink tumors before surgery.
-
Exploring a new treatment for high blood pressure using remote ischemic conditioning
This study is testing a new treatment called remote ischemic conditioning to see if it can help people with high blood pressure feel better when used with their regular medication.
Quick answers
How many clinical trials run by The First Hospital of Jilin University are recruiting right now?
53, as of November 12, 2026. 3 of them were first registered in the last 30 days. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
All of them have sites in China. Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 2: 10, Phase 3: 4, Phase 4: 3, Phase 1/2: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.